Systemic Lupus Erythematosus and Outcomes in First and Subsequent Births Based on Data From a National Birth Registry

Arthritis Care and Research

Volumn 66, Issue 11, 2014, Pages 1718-1724

  Wallenius, Marianne ^a   Salvesen, Kjell Å ^a,b   Daltveit, Anne K ^c   Skomsvoll, Johan F ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b LUND UNIVERSITY   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APGAR SCORE; ARTICLE; BIRTH; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DYSTOCIA; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; INFERTILITY THERAPY; INSTRUMENTAL DELIVERY; LABOR INDUCTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; NORWAY; PERINATAL DEATH; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; REGISTER; SMALL FOR DATE INFANT; SMOKING HABIT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 85007235935     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22373     Document Type: Article

References (42)

1. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv 2011;66:639–53.
2. Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007;33:237–52.
3. Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011;50:657–64.
4. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199:127.e1–6.
5. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010;5:2060–8.
6. Vinet E, Clarke AE, Gordon C, Urowitz MB, Hanly JG, Pineau CA, et al. Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011;63:1068–72.
7. Vinet E, Labrecque J, Pineau CA, Clarke AE, St-Pierre Y, Platt R, et al. A population-based assessment of live births in women with systemic lupus erythematosus. Ann Rheum Dis 2012;71:557–9.
8. Yan YS, Krizova A, Ouimet JM, Pope JE. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J 2008;2:89–98.
9. Liu J, Zhao Y, Song Y, Zhang W, Bian X, Yang J, et al. Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med 2012;25:261–6.
10. Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998;25:1526–30.
11. Skomsvoll JF, Ostensen M, Irgens LM, Baste V. Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway. Scand J Rheumatol 1999;28:352–6.
12. Cunningham FD, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, Hankins GV, et al.Williams obstetrics. 20th ed.Stamford (CT):Appleton Lange; 1997.
13. O'Driscoll K, Meagher D, Robson M.Active management of labour. 4th ed.London:Mosby; 2003.
14. Shah PS. Parity and low birth weight and preterm birth: a systematic review and meta-analyses. Acta Obstet Gynecol Scand 2010;89:862–75.
15. Betran AP, Gulmezoglu AM, Robson M, Merialdi M, Souza JP, Wojdyla D, et al. WHO global survey on maternal and perinatal health in Latin America: classifying caesarean sections. Reprod Health 2009;6:18.
16. O'Driscoll K, Jackson RJ, Gallagher JT. Prevention of prolonged labour. BMJ 1969;2:477–80.
17. O'Driscoll K, Stronge JM, Minogue M. Active management of labour. BMJ 1973;3:135–7.
18. Irgens LM. The Medical Birth Registry of Norway: a source for epidemiological and clinical research. Scand J Rheumatol Suppl 1998;107:105–8.
19. Irgens LM. The Medical Birth Registry of Norway: epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000;79:435–9.
20. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892–8.
21. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993;341:1447–51.
22. European Surveillance of Congenital Anomalies. EUROCAT Guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomalies. September 2005. URL: http://eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf.
23. Terada M, Matsuda Y, Ogawa M, Matsui H, Satoh S. Effects of maternal factors on birth weight in Japan. J Pregnancy 2013;2013:172395.
24. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP, Davis RO, et al. Smoking, maternal age, fetal growth, and gestational age at delivery. Am J Obstet Gynecol 1990;162:53–8.
25. Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus 2010;19:1665–73.
26. Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 2011;38:1906–13.
27. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2009;24:519–25.
28. Kwok LW, Tam LS, Zhu T, Leung YY, Li E. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 2011;20:829–36.
29. Wei Q, Ouyang Y, Zeng W, Duan L, Ge J, Liao H. Pregnancy complicating systemic lupus erythematosus: a series of 86 cases. Arch Gynecol Obstet 2011;284:1067–71.
30. Kane EV, Calderwood C, Dobbie R, Morris C, Roman E, Greer IA. A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005. Eur J Obstet Gynecol Reprod Biol 2013;169:223–9.
31. Skomsvoll JF, Ostensen M, Irgens LM, Baste V. Pregnancy complications and delivery practice in women with connective tissue disease and inflammatory rheumatic disease in Norway. Acta Obstet Gynecol Scand 2000;79:490–5.
32. Molteni RA. Placental growth and fetal/placental weight (F/P) ratios throughout gestation: their relationship to patterns of fetal growth. Semin Perinatol 1984;8:94–100.
33. Williams LA, Evans SF, Newnham JP. Prospective cohort study of factors influencing the relative weights of the placenta and the newborn infant. BMJ 1997;314:1864–8.
34. Hutcheon JA, McNamara H, Platt RW, Benjamin A, Kramer MS. Placental weight for gestational age and adverse perinatal outcomes. Obstet Gynecol 2012;119:1251–8.
35. De Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009;60:3196–206.
36. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004;18:93–101.
37. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209.
38. Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res Ther 2012;14:208.
39. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658–66.
40. Shand AW, Algert CS, March L, Roberts CL. Second pregnancy outcomes for women with systemic lupus erythematosus. Ann Rheum Dis 2013;72:547–51.
41. Skomsvoll J, Ostensen M, Baste V, Irgens L. Validity of a rheumatic disease diagnosis in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2002;81:831–4.
42. The Norwegian Medical Association. Veileder i fødselshjelp Oslo. 2014. URL: http://www.legeforeningen.no/Fagmed/Norsk-gynekologisk-forening/Veiledere/Veileder-i-fodselshjelp-2014/Inflammatoriske-revmatiske-sykdommer-og-kollagenoser/.